Neuberg Diagnostics & Meditrina host CME on interventional cardiology & genomic medicine

Leading healthcare professionals convene to discuss advancements in interventional cardiology and genomics emphasizing personalized treatment approaches

0
103
New Delhi: The Continuing Medical Education (CME) event organized by Neuberg Diagnostics and Meditrina Hospital in Kollam brought together over 50 esteemed experts from Kerala and Tamil Nadu to delve into the latest advancements in interventional cardiology and genomic medicine.
Led by Dr. Blessvin Jino, Consultant Interventional Cardiologist at Meditrina Hospital, and Sushma Patil, Lead Genetic Counselor at Neuberg Centre for Genomic Medicine, the event aimed to shed light on new horizons in interventional cardiology and the integration of pharmacogenomics into modern healthcare practices.
Dr. Jino’s presentation on “New Horizons in Interventional Cardiology” provided valuable insights into emerging trends and technologies in the field, while Patil’s session on “Integrating Pharmacogenomics in Modern Day Healthcare practice and the pivotal role of genomics in hereditary screening” emphasized the pivotal role of genomics in hereditary screening and personalized medicine. She highlighted how an individual’s genetic makeup influences drug metabolism, the risk for adverse drug reactions, and determining the ideal dosage based on different pharmacogenomics guidelines like the Clinical Pharmacogenetics Implementation Consortium (CPIC).
Rejith Rajan, Chief Operating Officer of Meditrina Hospital, expressed excitement about the collaboration, stating, “Neuberg Diagnostics and Meditrina Hospital are thrilled to host this CME on Advances in Interventional Cardiology and Genomic Medicine in Kollam. This event underscores our dedication to staying at the forefront of medical innovation and enhancing patient outcomes. By bringing together leading experts in these fields, we aim to provide valuable insights and knowledge that will benefit both our medical professionals and the community. This collaboration highlights our commitment to excellence in healthcare and our ongoing efforts to integrate the latest advancements into our practice. With the addition of our clinical oncologist, the Meditrina Hospital enhances its oncology tests, providing cutting-edge diagnostics and personalized cancer care.”
The conference served as a platform for medical professionals to exchange knowledge, share experiences, and discuss the future directions of healthcare.